Dual function inhibitors of relevance to chronic obstructive pulmonary disease
Alliston, Kevin R.
Groutas, William C.
MetadataShow full item record
Bioorganic & medicinal chemistry letters. 2011 May 15; 21(10): 3177-80.
The general strategy and rationale underlying the design of COPD therapeutics that possess protease inhibitory activity and are also capable of releasing a species that attenuates inflammation by inhibiting caspase-1, are described. The synthesis and in vitro biochemical evaluation of a dual function molecule that sequentially inhibits HNE and caspase-1 in a time-dependent manner is reported.
Click on the DOI link below to access the article (may not be free).